GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Polaris Group (TPE:6550) » Definitions » Interest Coverage

Polaris Group (TPE:6550) Interest Coverage : 0 (At Loss) (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Polaris Group Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Polaris Group's Operating Income for the three months ended in Dec. 2024 was NT$-847.4 Mil. Polaris Group's Interest Expense for the three months ended in Dec. 2024 was NT$-13.0 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Polaris Group's Interest Coverage or its related term are showing as below:


TPE:6550's Interest Coverage is not ranked *
in the Biotechnology industry.
Industry Median: 113.1
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Polaris Group Interest Coverage Historical Data

The historical data trend for Polaris Group's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Polaris Group Interest Coverage Chart

Polaris Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Coverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Polaris Group Quarterly Data
Jun19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Polaris Group's Interest Coverage

For the Biotechnology subindustry, Polaris Group's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Polaris Group's Interest Coverage Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Polaris Group's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Polaris Group's Interest Coverage falls into.


;
;

Polaris Group Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Polaris Group's Interest Coverage for the fiscal year that ended in Dec. 2024 is calculated as

Here, for the fiscal year that ended in Dec. 2024, Polaris Group's Interest Expense was NT$-57.1 Mil. Its Operating Income was NT$-2,634.8 Mil. And its Long-Term Debt & Capital Lease Obligation was NT$1,800.2 Mil.

Polaris Group did not have earnings to cover the interest expense.

Polaris Group's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Here, for the three months ended in Dec. 2024, Polaris Group's Interest Expense was NT$-13.0 Mil. Its Operating Income was NT$-847.4 Mil. And its Long-Term Debt & Capital Lease Obligation was NT$1,800.2 Mil.

Polaris Group did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Polaris Group  (TPE:6550) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Polaris Group Interest Coverage Related Terms

Thank you for viewing the detailed overview of Polaris Group's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Polaris Group Business Description

Traded in Other Exchanges
N/A
Address
NO.298, Ruiguang Road, 7th floor, Neihu District, Taipei, TWN
Polaris Group is a multinational biotechnology company focused on developing novel anti-cancer therapies. The company's lead therapeutic Pegargiminase (ADI PEG 20), is a biologic in late-stage clinical development for a wide range of cancers, including hepatocellular carcinoma, mesothelioma, pancreatic cancer, non-small cell lung cancer, melanoma, acute myeloid leukemia and others. Polaris Group is also involved in every stage of the drug development process.

Polaris Group Headlines

No Headlines